A developer of implanted devices to record signals from brain cells received funding to advance a smaller and more durable electrode array. . . . → Read More: NIH Funds Brain-Computer Implant Device
|
|||||
       
  |
A developer of delivery methods for gene therapies promising greater safety for patients is raising $26 million in its first venture funding round. . . . → Read More: Gene Therapy Delivery Company Gains $26M in Early Funds  Comments are closed  Finance, New products  biomedical, biotechnology, chemistry, entrepreneurs, equity, genomics, investment, licensing, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, university, venture capital 
A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain. . . . → Read More: Delivery Tech Licensed for CBD Epilepsy Nasal Spray Comments are closed Intellectual property, New products biomedical, chemistry, engineering, licensing, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, U.K. 
A cancer center and biotechnology enterprise are developing gene-edited therapies working in the gut to reduce adverse effects from cancer immunotherapies. . . . → Read More: Gene-Edited Treatments in Works for Safer Cancer Therapies One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, cancer, Europe, genomics, life sciences, pharmaceuticals, preclinical, university 
An antiviral nasal spray is shown in tests with lab mice to prevent infection from SARS-CoV-2 viruses and reduce disease-causing cytokines. . . . → Read More: Nasal Spray Shown to Stop Covid-19 Infection, Disease Comments are closed New products Australia, biomedical, biotechnology, chemistry, Covid-19, life sciences, pharmaceuticals, physical sciences, preclinical 
A biotechnology company is advancing a vaccine to protect against disease from SARS-CoV-2 variants, with new support from the organization CEPI. . . . → Read More: CEPI Funding Covid-19 Variant Vaccine One comment - (Comments are closed) Finance, New products Africa, biomedical, biotechnology, clinical trials, Covid-19, Europe, genomics, grant, life sciences, pharmaceuticals, preclinical 
A one year-old biotechnology company developing treatments for diseases of microglia cells in the brain, is raising $90 million in new venture funds. . . . → Read More: Biotech Start-Up Gains $90M for Neurodegenerative Diseases Comments are closed Finance, New products biomedical, biotechnology, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, preclinical, university, venture capital 
A biotechnology company received a foundation grant for an implanted device to prevent HIV infection and unwanted pregnancy in women. . . . → Read More: Gates Grant Funds HIV-Birth Control Implant Comments are closed Finance, New products Africa, biomedical, biotechnology, grant, HIV, life sciences, medical device, pharmaceuticals, preclinical, university 
Drug maker Bayer is acquiring a company discovering new therapies with a technology that reveals complex protein targets considered difficult to address. . . . → Read More: Protein Chemistry Biotech Acquired in $2B Deal One comment - (Comments are closed) Finance biomedical, biotechnology, chemistry, entrepreneurs, Europe, investment, life sciences, merger, pharmaceuticals, physical sciences, preclinical 
National Cancer Institute is funding research on using programmable synthetic messenger RNA to treat two types of solid tumor cancer. . . . → Read More: NIH Funds Programmable mRNA to Treat Cancer Comments are closed Finance, New products biomedical, biotechnology, cancer, entrepreneurs, genomics, grant, life sciences, NIH, pharmaceuticals, preclinical, university |
|
|||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
